Evidence map›Paper›PMID 30166290›Full record

Trial reportBMJ open2018

Effects of a 6-month self-rehabilitation programme in addition to botulinum toxin injections and conventional physiotherapy on limitations of patients with spastic hemiparesis following stroke (ADJU-TOX): protocol study for a randomised controlled, investigator blinded study.

Celine Bonnyaud, Philippe Gallien, Pierre Decavel, Philippe Marque, Claire Aymard, Frédéric Pellas, Marie-Eve Isner, François Constant Boyer, François Muller, Jean-Christophe Daviet and 11 more

Registry-linked trialOpen access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02944929 (Randomised Controlled Trial to Evaluate the Effect of a Self-rehabilitation Program in Addition to Usual Treatment for Spasticity), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02944929 phase3unknown statusnot on this map

Randomised Controlled Trial to Evaluate the Effect of a Self-rehabilitation Program in Addition to Usual Treatment for Spasticity (Repeated Botulinum Toxin Injections and Physiotherapy) on Impairment and Activity Limitation in Patients With Spastic Hemiparesis Following Stroke

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2018 to 2021Enrolled220ConditionsSpastic HemiparesisArmsSelf-rehabilitation program
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 1 country.

Celine BonnyaudService de Physiologie et d'exploration Fonctionnelle, Hôpital Raymond Poincaré APHP, Garches, Université Versailles Saint Quentin en Yvelines, Garches, France.
Philippe GallienService de Médecine Physique et de Réadaptation, Pole Saint-Helier, Rennes, Bretagne, France.
Pierre DecavelService de Médecine Physique et de Réadaptation, Hôpital Jean-Minjoz, Besançon, France.
Philippe MarqueService de Médecine Physique et de Réadaptation, Hôpital Rangueil, Toulouse, France.
Claire AymardService de Médecine Physique et de Réadaptation, Fondation Hospitaliere Sainte-Marie, Paris, France.
Frédéric PellasService Rééducation Post Réanimation, Unité Cérébro-Lésés, Hopital Carémeau, Nimes, France.
Marie-Eve IsnerService de Médecine Physique et de Réadaptation, Institut Réadaptation Clémenceau, Strasbourg, France.
François Constant BoyerService de Médecine Physique et de Réadaptation, Hôpital Sebastopol, Reims, France.
François MullerService de Médecine Physique et de Réadaptation, Clinique Les Embruns, Bidart, France.
Jean-Christophe DavietService de Médecine Physique et de Réadaptation, Hôpital Rebeyrol, Limoges, France.
Patrick DehailService de Médecine Physique et de Réadaptation, Hôpital Pellegrin, Bordeaux, France.
Brigitte Perrouin-VerbeService de Médecine Physique et de Réadaptation, Hôpital Saint Jacques, Nantes, France.
Nicolas BayleService de Médecine Physique et de Réadaptation, Albert Chenevier, Hôpital Henri Mondor, Créteil, France.
Emmanuel CoudeyreService de Médecine Physique et de Réadaptation, Hôpital Nord, Clermont-Ferrand, France.
Dominic PerennouService de Médecine Physique et de Réadaptation, Neurologie, Centre Hospitalier Universitaire, Grenoble, France.
Isabelle LaffontService de Médecine Physique et de Réadaptation, Centre Hospitalier Regional Universitaire de Montpellier, Montpellier, France.
Jacques RopersUnité de Recherche Clinique, Paris Île-de-France Ouest (URCPO), Hôpital Raymond Poincaré, APHP, Garches, France.
Nabila-Yasmine Domingo-SaidjiUnité de Recherche Clinique, Paris Île-de-France Ouest (URCPO), Hôpital Raymond Poincaré, APHP, Garches, France.
Djamel BensmailService de Physiologie et d'exploration Fonctionnelle, Hôpital Raymond Poincaré APHP, Garches, Université Versailles Saint Quentin en Yvelines, Garches, France.
Nicolas RocheService de Physiologie et d'exploration Fonctionnelle, Hôpital Raymond Poincaré APHP, Garches, Université Versailles Saint Quentin en Yvelines, Garches, France.
ADJU-TOX Study Group
Institut Régional de Médecine Physique et de Réadaptation · FRInstitut de Génomique Fonctionnelle · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Universitaire de Montpellier · FRCentre Hospitalier Universitaire de Nîmes · FRHôpital Albert-Chenevier · FRHôpital Rangueil · FRHôpital Saint-Jacques · FRHôpitaux Universitaires Paris-Ouest · FRUniversité de Versailles Saint-Quentin-en-Yvelines · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHome-based self-rehabilitation programmes combined with botulinum toxin injections (BTIs) appear to be a relevant approach to increase the recommended intensive rehabilitation of patients with spasticity following a stroke. The literature highlights a lack of evidence of beneficial effects of this adjuvant therapy to reduce limitations of patients with stroke. The aim of this study is to assess the effects of a 6-month self-rehabilitation programme in adjunction to BTI, in comparison with BTI alone, to reduce limitations of patients with spasticity following a stroke. METHODS AND ANALYSIS: 220 chronic patients will participate to this multicentre, prospective, randomised, controlled, assessor blinded study. All patients will benefit from two successive BTI (3 months apart), and patients randomised in the self-rehabilitation group will perform in adjunction 6 months of self-rehabilitation at home. All patients continue their conventional physiotherapy. The main outcome is the primary treatment goal (PTG), which will be determined jointly by the patient and the medical doctor using Goal Attainment Scaling. Impairments and functions, quality of life, mood and fatigue will be assessed. Botulinum toxin will be injected into the relevant muscles according to the PTG. Patients in the self-rehab group will be taught the self-rehabilitation programme involving respectively 10 min of stretching, 10 min of strengthening and 10 min of task-oriented exercises, corresponding to their PTG. Compliance to the self-rehabilitation programme will be monitored. ETHICS AND DISSEMINATION: Patients will sign written informed consent. Ethical approval was obtained from ethics committee. The results will be disseminated in a peer-reviewed journal and presented at international congresses. The results will also be disseminated to patients. TRIAL REGISTRATION NUMBER: NCT02944929.

Indexed as

Physical Therapy ModalitiesAdolescentAdultAgedBotulinum ToxinsClinical ProtocolsCombined Modality TherapyFemaleHumansMaleMiddle AgedParaparesis, SpasticSelf CareStrokeStroke RehabilitationYoung AdultBotulinum ToxinsBotulinum ToxinGoal Attainment ScalingSelf-rehabilitationSpasticity ManagementStroke

Identifiers

PMID30166290
PMCPMC6119443
OpenAlexW2888838073

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.